KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Cash from Financing Activities (2016 - 2025)

Cardinal Health's Cash from Financing Activities history spans 17 years, with the latest figure at -$519.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 122.3% year-over-year to -$519.0 million; the TTM value through Dec 2025 reached -$476.0 million, down 124.3%, while the annual FY2025 figure was $1.9 billion, 329.04% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$519.0 million at Cardinal Health, down from -$110.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $2.3 billion in Q4 2024 and bottomed at -$1.3 billion in Q3 2021.
  • The 5-year median for Cash from Financing Activities is -$473.5 million (2021), against an average of -$301.2 million.
  • The largest annual shift saw Cash from Financing Activities plummeted 538.38% in 2021 before it soared 759.21% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$444.0 million in 2021, then increased by 18.47% to -$362.0 million in 2022, then increased by 2.49% to -$353.0 million in 2023, then skyrocketed by 759.21% to $2.3 billion in 2024, then plummeted by 122.3% to -$519.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Cash from Financing Activities are -$519.0 million (Q4 2025), -$110.0 million (Q3 2025), and $656.0 million (Q2 2025).